China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.20
+0.56 (6.48%)
At close: Mar 27, 2026

HKG:2877 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,9506,4967,2905,4925,7335,205
Market Cap Growth
6.98%-10.88%32.74%-4.22%10.16%29.89%
Enterprise Value
-1,097-75896724537224
Last Close Price
9.208.609.046.396.305.37
PE Ratio
6.566.158.155.147.027.62
Forward PE
7.347.006.295.107.576.45
PS Ratio
1.991.861.811.101.281.32
PB Ratio
0.770.720.920.710.800.72
P/TBV Ratio
0.790.740.940.730.820.75
P/FCF Ratio
--8.326.325.176.96
P/OCF Ratio
--7.115.354.576.03
EV/Sales Ratio
--0.240.010.120.06
EV/EBITDA Ratio
--1.020.020.540.26
EV/EBIT Ratio
--1.090.020.670.34
EV/FCF Ratio
--1.100.030.480.30
Debt / Equity Ratio
0.040.040.050.040.000.00
Debt / EBITDA Ratio
0.450.450.380.290.010.02
Debt / FCF Ratio
--0.420.380.010.02
Net Debt / Equity Ratio
-0.90-0.90-0.82-0.80-0.79-0.71
Net Debt / EBITDA Ratio
-9.80-9.80-6.90-5.51-5.68-5.95
Net Debt / FCF Ratio
---7.47-7.12-5.14-6.88
Asset Turnover
0.300.300.390.510.510.45
Inventory Turnover
1.161.161.111.441.631.58
Quick Ratio
3.413.413.172.973.664.62
Current Ratio
3.713.713.513.354.075.19
Return on Equity (ROE)
12.23%12.23%11.59%14.45%11.77%9.52%
Return on Assets (ROA)
4.09%4.09%5.33%6.81%5.78%4.63%
Return on Invested Capital (ROIC)
61.43%47.49%44.71%54.89%36.93%20.95%
Return on Capital Employed (ROCE)
8.30%8.30%11.00%13.60%10.90%8.80%
Earnings Yield
15.21%16.27%12.26%19.45%14.25%13.13%
FCF Yield
--12.02%15.81%19.33%14.37%
Dividend Yield
5.49%-6.35%7.24%5.75%8.92%
Payout Ratio
--48.56%32.73%33.45%81.39%
Buyback Yield / Dilution
0.20%0.19%---0.03%0.21%
Total Shareholder Return
5.68%0.19%6.35%7.24%5.71%9.13%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.